SEC Filing Details
Document Details
Form
Filing Date
May 6, 2024
Document Date
Mar 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.